ID   LCLT1_HUMAN             Reviewed;         414 AA.
AC   Q6UWP7; A6H8Z7; Q8N1Q7;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-JUN-2023, entry version 150.
DE   RecName: Full=Lysocardiolipin acyltransferase 1;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q3UN02};
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 8 {ECO:0000303|PubMed:16620771};
DE            Short=1-AGP acyltransferase 8;
DE            Short=1-AGPAT 8;
DE            EC=2.3.1.51 {ECO:0000269|PubMed:16620771};
DE   AltName: Full=Acyl-CoA:lysocardiolipin acyltransferase 1;
GN   Name=LCLAT1;
GN   Synonyms=AGPAT8 {ECO:0000303|PubMed:16620771}, ALCAT1, LYCAT;
GN   ORFNames=UNQ1849/PRO3579;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   ASP-206.
RX   PubMed=16620771; DOI=10.1016/j.abb.2006.03.014;
RA   Agarwal A.K., Barnes R.I., Garg A.;
RT   "Functional characterization of human 1-acylglycerol-3-phosphate
RT   acyltransferase isoform 8: cloning, tissue distribution, gene structure,
RT   and enzymatic activity.";
RL   Arch. Biochem. Biophys. 449:64-76(2006).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-206 AND LEU-207.
RX   PubMed=19075029; DOI=10.1194/jlr.m800567-jlr200;
RA   Zhao Y., Chen Y.-Q., Li S., Konrad R.J., Cao G.;
RT   "The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin
RT   acyltransferase is an acyltransferase of multiple anionic
RT   lysophospholipids.";
RL   J. Lipid Res. 50:945-956(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Exhibits acyl-CoA:lysocardiolipin acyltransferase (ALCAT)
CC       activity; catalyzes the reacylation of lyso-cardiolipin to cardiolipin
CC       (CL), a key step in CL remodeling (By similarity). Recognizes both
CC       monolysocardiolipin and dilysocardiolipin as substrates with a
CC       preference for linoleoyl-CoA and oleoyl-CoA as acyl donors (By
CC       similarity). Also exhibits 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase activity (AGPAT) activity; converts 1-acyl-sn-glycerol-
CC       3- phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-
CC       glycerol-3- phosphate (phosphatidic acid or PA) by incorporating an
CC       acyl moiety at the sn-2 position of the glycerol backbone
CC       (PubMed:16620771). Possesses both lysophosphatidylinositol
CC       acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase
CC       (LPGAT) activities (PubMed:19075029). Required for establishment of the
CC       hematopoietic and endothelial lineages (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UN02, ECO:0000269|PubMed:16620771,
CC       ECO:0000269|PubMed:19075029}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphate + an acyl-CoA = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:19709,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:58608; EC=2.3.1.51;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19710;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) + an acyl-CoA
CC         = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + CoA;
CC         Xref=Rhea:RHEA:33195, ChEBI:CHEBI:57287, ChEBI:CHEBI:57880,
CC         ChEBI:CHEBI:58342, ChEBI:CHEBI:64771;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33196;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-sn-glycero-3-phospho-(1'-sn-glycerol) + an acyl-CoA =
CC         1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) + CoA;
CC         Xref=Rhea:RHEA:33203, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:64716, ChEBI:CHEBI:64840;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33204;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate
CC         = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:33187, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57518, ChEBI:CHEBI:64839;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33188;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphate = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37131, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74546;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37132;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z,12Z)-octadecadienoyl-sn-glycero-
CC         3-phosphate = 1-(9Z,12Z)-octadecadienoyl-2-(9Z)-octadecenoyl-sn-
CC         glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37135, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:74547, ChEBI:CHEBI:74548;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37136;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z,12Z,15Z)-octadecatrienoyl-sn-
CC         glycero-3-phosphate = 1-(9Z,12Z,15Z)-octadecatrienoyl-2-(9Z)-
CC         octadecenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37139,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:74549,
CC         ChEBI:CHEBI:74550; Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37140;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + hexadecanoyl-CoA
CC         = 1-(9Z)-octadecenoyl-2-hexadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37143, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74551;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37144;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + octadecanoyl-CoA
CC         = 1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37147, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74552;
CC         Evidence={ECO:0000269|PubMed:16620771};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37148;
CC         Evidence={ECO:0000305|PubMed:16620771};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-acyl-sn-glycero-3-phospho-(1'-sn-
CC         glycerol) = 1-acyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-sn-
CC         glycerol) + CoA; Xref=Rhea:RHEA:37619, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:64840, ChEBI:CHEBI:75173;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37620;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + a 1-acyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol) = a 1-acyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1D-
CC         myo-inositol) + CoA; Xref=Rhea:RHEA:37623, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:64771, ChEBI:CHEBI:75116;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37624;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol) +
CC         hexadecanoyl-CoA = 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol) + CoA; Xref=Rhea:RHEA:35871, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:72833, ChEBI:CHEBI:72835;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35872;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol) +
CC         octadecanoyl-CoA = 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-
CC         phospho-(1D-myo-inositol) + CoA; Xref=Rhea:RHEA:35875,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:72833,
CC         ChEBI:CHEBI:72836; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35876;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phospho-
CC         (1D-myo-inositol) = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1D-myo-inositol) + CoA; Xref=Rhea:RHEA:35879,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:72833,
CC         ChEBI:CHEBI:72837; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35880;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phospho-(1D-myo-inositol) = 1-hexadecanoyl-2-(9Z,12Z-
CC         octadecadienoyl)-sn-glycero-3-phospho-(1D-myo-inositol) + CoA;
CC         Xref=Rhea:RHEA:35883, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:72833, ChEBI:CHEBI:72838;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35884;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-hexadecanoyl-sn-
CC         glycero-3-phospho-(1D-myo-inositol) = 1-hexadecanoyl-2-
CC         (5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-D-myo-inositol
CC         + CoA; Xref=Rhea:RHEA:35867, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:72833, ChEBI:CHEBI:72834;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35868;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) +
CC         hexadecanoyl-CoA = 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-sn-
CC         glycerol) + CoA; Xref=Rhea:RHEA:35851, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:72829, ChEBI:CHEBI:75158;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35852;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol) +
CC         octadecanoyl-CoA = 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:35887,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:72839,
CC         ChEBI:CHEBI:75158; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35888;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phospho-
CC         (1'-sn-glycerol) = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:35891,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:72841,
CC         ChEBI:CHEBI:75158; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35892;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1-hexadecanoyl-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) = 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-
CC         sn-glycero-3-phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:35895,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:72840,
CC         ChEBI:CHEBI:75158; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35896;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-tetradecanoyl-sn-glycero-3-phospho-
CC         (1'-sn-glycerol) = 1-tetradecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:37643,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:72826,
CC         ChEBI:CHEBI:75161; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37644;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-phospho-
CC         (1'-sn-glycerol) = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:37647,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:72827,
CC         ChEBI:CHEBI:72845; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37648;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phospho-(1'-sn-glycerol) + CoA; Xref=Rhea:RHEA:37651,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:72828,
CC         ChEBI:CHEBI:75163; Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37652;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol) +
CC         dodecanoyl-CoA = 1-hexadecanoyl-2-dodecanoyl-sn-glycero-3-phospho-
CC         (1D-myo-inositol) + CoA; Xref=Rhea:RHEA:37639, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:72833, ChEBI:CHEBI:75160;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37640;
CC         Evidence={ECO:0000305|PubMed:19075029};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1',3'-bis-[1-acyl-sn-glycero-3-
CC         phospho]-glycerol = 1'-[1-acyl-2-(9Z)-octadecenoyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-hydroxy-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:37615, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:75137, ChEBI:CHEBI:75139;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37616;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1'-[1,2-diacyl-sn-glycero-3-
CC         phospho],3'-[1-acyl-sn-glycero-3-phospho]-glycerol = 1'-[1,2-diacyl-
CC         sn-glycero-3-phospho],3'-[1-acyl,2-(9Z)-octadecenoyl-sn-glycero-3-
CC         phospho]-glycerol + CoA; Xref=Rhea:RHEA:37611, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:64743, ChEBI:CHEBI:75140;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37612;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1'-[1,2-diacyl-sn-glycero-3-
CC         phospho],3'-[1-acyl-sn-glycero-3-phospho]-glycerol = 1'-[1,2-diacyl-
CC         sn-glycero-3-phospho],3'-[1-acyl,2-(9Z,12Z)-octadecadienoyl-sn-
CC         glycero-3-phospho]-glycerol + CoA; Xref=Rhea:RHEA:37675,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57383, ChEBI:CHEBI:64743,
CC         ChEBI:CHEBI:75205; Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37676;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-[1,2-diacyl-sn-glycero-3-phospho],3'-[1-acyl-sn-glycero-3-
CC         phospho]-glycerol + dodecanoyl-CoA = 1'-[1,2-diacyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-dodecanoyl-sn-glycero-3-phospho]-glycerol +
CC         CoA; Xref=Rhea:RHEA:37679, ChEBI:CHEBI:57287, ChEBI:CHEBI:57375,
CC         ChEBI:CHEBI:64743, ChEBI:CHEBI:75203;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37680;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis-[1-acyl-sn-glycero-3-phospho]-glycerol + dodecanoyl-
CC         CoA = 1'-[1-acyl-2-dodecanoyl-sn-glycero-3-phospho],3'-[1-acyl,2-
CC         hydroxy-sn-glycero-3-phospho]-glycerol + CoA; Xref=Rhea:RHEA:37683,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57375, ChEBI:CHEBI:75137,
CC         ChEBI:CHEBI:75201; Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37684;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + a 1-acyl-sn-glycero-3-phosphate = a 1-
CC         acyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37427, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57970, ChEBI:CHEBI:74917;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37428;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 1',3'-bis-[1-acyl-sn-glycero-3-
CC         phospho]-glycerol = 1'-[1-acyl-2-(9Z,12Z)-octadecadienoyl-sn-glycero-
CC         3-phospho],3'-[1-acyl,2-hydroxy-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:37687, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:75137, ChEBI:CHEBI:75209;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37688;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis-[1-acyl-sn-glycero-3-phospho]-glycerol +
CC         hexadecanoyl-CoA = 1'-[1-acyl-2-hexadecanoyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-hydroxy-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:37691, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:75137, ChEBI:CHEBI:75207;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37692;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis-[1-acyl-sn-glycero-3-phospho]-glycerol +
CC         octadecanoyl-CoA = 1'-[1-acyl-2-octadecanoyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-hydroxy-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:37695, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:75137, ChEBI:CHEBI:75208;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37696;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-[1,2-diacyl-sn-glycero-3-phospho],3'-[1-acyl-sn-glycero-3-
CC         phospho]-glycerol + octanoyl-CoA = 1'-[1,2-diacyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-octanoyl-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:38623, ChEBI:CHEBI:57287, ChEBI:CHEBI:57386,
CC         ChEBI:CHEBI:64743, ChEBI:CHEBI:75990;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38624;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis-[1-acyl-sn-glycero-3-phospho]-glycerol + octanoyl-
CC         CoA = 1'-[1-acyl-2-octanoyl-sn-glycero-3-phospho],3'-[1-acyl,2-
CC         hydroxy-sn-glycero-3-phospho]-glycerol + CoA; Xref=Rhea:RHEA:38627,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57386, ChEBI:CHEBI:75137,
CC         ChEBI:CHEBI:75993; Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38628;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-[1,2-diacyl-sn-glycero-3-phospho],3'-[1-acyl-sn-glycero-3-
CC         phospho]-glycerol + hexadecanoyl-CoA = 1'-[1,2-diacyl-sn-glycero-3-
CC         phospho],3'-[1-acyl,2-hexadecanoyl-sn-glycero-3-phospho]-glycerol +
CC         CoA; Xref=Rhea:RHEA:38631, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:64743, ChEBI:CHEBI:75994;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38632;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1'-[1,2-diacyl-sn-
CC         glycero-3-phospho],3'-[1-acyl-sn-glycero-3-phospho]-glycerol = 1'-
CC         [1,2-diacyl-sn-glycero-3-phospho],3'-[1-acyl,2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phospho]-glycerol + CoA;
CC         Xref=Rhea:RHEA:38635, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:64743, ChEBI:CHEBI:75995;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38636;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1',3'-bis-[1-acyl-sn-
CC         glycero-3-phospho]-glycerol = 1'-[1-acyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phospho],3'-[1-acyl,2-hydroxy-sn-
CC         glycero-3-phospho]-glycerol + CoA; Xref=Rhea:RHEA:38639,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:75137,
CC         ChEBI:CHEBI:75996; Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38640;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol) +
CC         octadecanoyl-CoA = a 1-acyl-2-octadecanoyl-sn-glycero-3-phospho-(1D-
CC         myo-inositol) + CoA; Xref=Rhea:RHEA:43960, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57394, ChEBI:CHEBI:64771, ChEBI:CHEBI:83939;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43961;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2-acyl-sn-glycero-3-phospho-D-myo-inositol + octadecanoyl-
CC         CoA = 1-octadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol +
CC         CoA; Xref=Rhea:RHEA:43964, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:64872, ChEBI:CHEBI:65055;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43965;
CC         Evidence={ECO:0000250|UniProtKB:Q3UN02};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=39 uM for arachidonoyl-CoA (20:4) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=289 uM for oleoyl-CoA (18:1) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=134 uM for linoleoyl-CoA (18:2) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=34 uM for stearoyl-CoA (18:0) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=53 uM for palmitoyl-CoA (16:0) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=54 uM for oleoyl-CoA (18:1) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=36 uM for linoleoyl-CoA (18:2) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=70 uM for stearoyl-CoA (18:0) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=34 uM for palmitoyl-CoA (16:0) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         Vmax=3230 nmol/min/mg enzyme toward arachidonoyl-CoA (20:4) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=7489 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=4696 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1078 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=11203 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=5514 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPGAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1358 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for LPGAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=3530 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for LPGAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1673 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for LPGAT
CC         activity {ECO:0000269|PubMed:19075029};
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-
CC       diacylglycerol from sn-glycerol 3-phosphate: step 2/3.
CC   -!- INTERACTION:
CC       Q6UWP7; Q9HD26: GOPC; NbExp=3; IntAct=EBI-10254507, EBI-349832;
CC       Q6UWP7; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-10254507, EBI-739832;
CC       Q6UWP7; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-10254507, EBI-79165;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19075029}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UWP7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UWP7-2; Sequence=VSP_026181, VSP_026182;
CC       Name=3;
CC         IsoId=Q6UWP7-3; Sequence=VSP_044307;
CC   -!- TISSUE SPECIFICITY: Expressed at higher level in heart, kidney and
CC       pancreas than in brain, spleen, liver, lung, small intestine and
CC       placenta. {ECO:0000269|PubMed:16620771, ECO:0000269|PubMed:19075029}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity and
CC       may constitute the binding site for the phosphate moiety of the
CC       glycerol-3-phosphate. {ECO:0000250|UniProtKB:Q9D517}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- CAUTION: PubMed:16620771 does not detect acyl-CoA:lysocardiolipin
CC       acyltransferase activity. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY358702; AAQ89065.1; -; mRNA.
DR   EMBL; AK095284; BAC04522.1; -; mRNA.
DR   EMBL; AC073255; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146817; AAI46818.1; -; mRNA.
DR   CCDS; CCDS1772.1; -. [Q6UWP7-1]
DR   CCDS; CCDS42670.1; -. [Q6UWP7-3]
DR   RefSeq; NP_001002257.1; NM_001002257.2. [Q6UWP7-3]
DR   RefSeq; NP_001291374.1; NM_001304445.1. [Q6UWP7-3]
DR   RefSeq; NP_872357.2; NM_182551.4. [Q6UWP7-1]
DR   RefSeq; XP_005264301.1; XM_005264244.1. [Q6UWP7-1]
DR   RefSeq; XP_005264302.1; XM_005264245.3. [Q6UWP7-3]
DR   RefSeq; XP_011531043.1; XM_011532741.2. [Q6UWP7-1]
DR   RefSeq; XP_011531044.1; XM_011532742.2.
DR   RefSeq; XP_011531045.1; XM_011532743.2.
DR   RefSeq; XP_016859235.1; XM_017003746.1. [Q6UWP7-3]
DR   AlphaFoldDB; Q6UWP7; -.
DR   BioGRID; 128972; 89.
DR   IntAct; Q6UWP7; 26.
DR   MINT; Q6UWP7; -.
DR   STRING; 9606.ENSP00000310551; -.
DR   BindingDB; Q6UWP7; -.
DR   SwissLipids; SLP:000000126; -.
DR   GlyGen; Q6UWP7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6UWP7; -.
DR   PhosphoSitePlus; Q6UWP7; -.
DR   SwissPalm; Q6UWP7; -.
DR   BioMuta; LCLAT1; -.
DR   DMDM; 74749398; -.
DR   EPD; Q6UWP7; -.
DR   jPOST; Q6UWP7; -.
DR   MassIVE; Q6UWP7; -.
DR   MaxQB; Q6UWP7; -.
DR   PaxDb; Q6UWP7; -.
DR   PeptideAtlas; Q6UWP7; -.
DR   ProteomicsDB; 67509; -. [Q6UWP7-1]
DR   ProteomicsDB; 67510; -. [Q6UWP7-2]
DR   ProteomicsDB; 790; -.
DR   TopDownProteomics; Q6UWP7-1; -. [Q6UWP7-1]
DR   Antibodypedia; 28989; 110 antibodies from 20 providers.
DR   DNASU; 253558; -.
DR   Ensembl; ENST00000309052.8; ENSP00000310551.4; ENSG00000172954.14. [Q6UWP7-1]
DR   Ensembl; ENST00000319406.8; ENSP00000368826.1; ENSG00000172954.14. [Q6UWP7-2]
DR   Ensembl; ENST00000379509.8; ENSP00000368823.3; ENSG00000172954.14. [Q6UWP7-3]
DR   GeneID; 253558; -.
DR   KEGG; hsa:253558; -.
DR   MANE-Select; ENST00000379509.8; ENSP00000368823.3; NM_001002257.3; NP_001002257.1. [Q6UWP7-3]
DR   UCSC; uc002rnj.3; human. [Q6UWP7-1]
DR   AGR; HGNC:26756; -.
DR   CTD; 253558; -.
DR   DisGeNET; 253558; -.
DR   GeneCards; LCLAT1; -.
DR   HGNC; HGNC:26756; LCLAT1.
DR   HPA; ENSG00000172954; Low tissue specificity.
DR   neXtProt; NX_Q6UWP7; -.
DR   OpenTargets; ENSG00000172954; -.
DR   PharmGKB; PA164722072; -.
DR   VEuPathDB; HostDB:ENSG00000172954; -.
DR   eggNOG; KOG1505; Eukaryota.
DR   GeneTree; ENSGT00950000182836; -.
DR   HOGENOM; CLU_041844_4_0_1; -.
DR   InParanoid; Q6UWP7; -.
DR   OrthoDB; 2906776at2759; -.
DR   PhylomeDB; Q6UWP7; -.
DR   TreeFam; TF314346; -.
DR   PathwayCommons; Q6UWP7; -.
DR   Reactome; R-HSA-1482798; Acyl chain remodeling of CL.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   SABIO-RK; Q6UWP7; -.
DR   SignaLink; Q6UWP7; -.
DR   UniPathway; UPA00557; UER00613.
DR   BioGRID-ORCS; 253558; 12 hits in 1154 CRISPR screens.
DR   ChiTaRS; LCLAT1; human.
DR   GenomeRNAi; 253558; -.
DR   Pharos; Q6UWP7; Tbio.
DR   PRO; PR:Q6UWP7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q6UWP7; protein.
DR   Bgee; ENSG00000172954; Expressed in left ventricle myocardium and 191 other tissues.
DR   ExpressionAtlas; Q6UWP7; baseline and differential.
DR   Genevisible; Q6UWP7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0012505; C:endomembrane system; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0016746; F:acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0008374; F:O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:UniProtKB.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; IBA:GO_Central.
DR   CDD; cd07990; LPLAT_LCLAT1-like; 1.
DR   InterPro; IPR032098; Acyltransf_C.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   PANTHER; PTHR10983; 1-ACYLGLYCEROL-3-PHOSPHATE ACYLTRANSFERASE-RELATED; 1.
DR   PANTHER; PTHR10983:SF16; LYSOCARDIOLIPIN ACYLTRANSFERASE 1; 1.
DR   Pfam; PF16076; Acyltransf_C; 1.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   SMART; SM00563; PlsC; 1.
DR   SUPFAM; SSF69593; Glycerol-3-phosphate (1)-acyltransferase; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Alternative splicing; Developmental protein;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..414
FT                   /note="Lysocardiolipin acyltransferase 1"
FT                   /id="PRO_0000291577"
FT   TRANSMEM        47..67
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        86..106
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        340..360
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        362..382
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           123..128
FT                   /note="HXXXXD motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D517"
FT   MOD_RES         221
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1..38
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_044307"
FT   VAR_SEQ         249..308
FT                   /note="KNLDAVHDITVAYPHNIPQSEKHLLQGDFPREIHFHVHRYPIDTLPTSKEDL
FT                   QLWCHKRW -> RRQSEGSKGPLQGELQITAQGNQRGHKQMEKHSMLMDWKNQYREIGH
FT                   TAQSNLQIQCYSH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_026181"
FT   VAR_SEQ         309..414
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_026182"
FT   VARIANT         290
FT                   /note="I -> V (in dbSNP:rs12471868)"
FT                   /id="VAR_032830"
FT   MUTAGEN         206
FT                   /note="D->C: Abolishes LPIAT and LPGAT activities."
FT                   /evidence="ECO:0000269|PubMed:16620771,
FT                   ECO:0000269|PubMed:19075029"
FT   MUTAGEN         206
FT                   /note="D->R: Does not increase enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16620771,
FT                   ECO:0000269|PubMed:19075029"
FT   MUTAGEN         207
FT                   /note="L->T: Abolishes LPIAT activity. No effect on LPGAT
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:19075029"
SQ   SEQUENCE   414 AA;  48920 MW;  F83A1911CC19F959 CRC64;
     MHSRGREIVV LLNPWSINEA VSSYCTYFIK QDSKSFGIMV SWKGIYFILT LFWGSFFGSI
     FMLSPFLPLM FVNPSWYRWI NNRLVATWLT LPVALLETMF GVKVIITGDA FVPGERSVII
     MNHRTRMDWM FLWNCLMRYS YLRLEKICLK ASLKGVPGFG WAMQAAAYIF IHRKWKDDKS
     HFEDMIDYFC DIHEPLQLLI FPEGTDLTEN SKSRSNAFAE KNGLQKYEYV LHPRTTGFTF
     VVDRLREGKN LDAVHDITVA YPHNIPQSEK HLLQGDFPRE IHFHVHRYPI DTLPTSKEDL
     QLWCHKRWEE KEERLRSFYQ GEKNFYFTGQ SVIPPCKSEL RVLVVKLLSI LYWTLFSPAM
     CLLIYLYSLV KWYFIITIVI FVLQERIFGG LEIIELACYR LLHKQPHLNS KKNE
//
